IRF7 inhibitor (SelectImmune/University of Lund)

N/A

Report date: 2025/03/20 15:11:17
NME

Base Information

Drug NameIRF7 inhibitor (SelectImmune/University of Lund)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionInterferon Regulatory Factor 7 inhibitors
TargetsInterferon Regulatory Factor 7
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSelectImmune Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesHamlet BioPharma AB
Inactive CompaniesSelectImmune Pharma AB
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A